FDA approves first new type of pain medication in 25 years
17 hours ago · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
16 hours ago · BOSTON, January 30, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non ...
Vertex’s non-opioid pain drug gets FDA approval in milestone for ...
16 hours ago · Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
FDA approves new painkiller that shows promise and
16 hours ago · The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ pill, Journavx, for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications like ibuprofen and acetaminophen.
FDA approves new type of nonopioid painkiller for acute pain
17 hours ago · The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain …
1 day ago · According to a new announcement, the FDA has approved suzetrigine (Vertex Pharmaceuticals), an oral selective NaV1.8 pain signal inhibitor, to treat patients who experience moderate-to-severe acute pain. Marketed as Journavx, the opioid therapy becomes the first new class of medicine to treat acute pain in over 20 years. 1 The new drug application (NDA) for suzetrigine, formally known as VX ...
FDA approves Journavx, new non-opioid painkiller from Vertex: …
17 hours ago · The Food and Drug Administration on Thursday approved a new non-opioid painkiller from Vertex Pharmaceuticals, a pill the drugmaker says poses no risk of addiction and could become an alternative ...
Vertex non-opioid pain drug Journavx appoved by FDA - STAT
1 day ago · Vertex Pharmaceuticals won FDA approval for a non-opioid drug for moderate to severe acute pain
FDA approves Vertex's Journavx pain drug - ABC7 Southwest …
16 hours ago · FDA approves Vertex's Journavx, a new pain drug designed to eliminate opioid addiction risks, marking a breakthrough in pain management
FDA approves Vertex non-opioid painkiller drug Journavx - CNBC
17 hours ago · The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
- Some results have been removed